In order to study if targeting the anti-apoptotic proteins can inhibit the ability of IBC cells to form tumor cell clusters and subsequent viability, we employed IBC patient primary tumor derived lines, SUM149 (triple negative, EGFR activation) and SUM190 (estrogen receptor negative, HER2 overexpression). Here, EGFR is linked to neoplasm.